GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.300
+0.035 (2.77%)
At close: Aug 13, 2025, 4:00 PM
1.310
+0.010 (0.77%)
After-hours: Aug 13, 2025, 7:27 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.25 million as of August 13, 2025. Its market cap has increased by 1.55% in one year.
Market Cap
3.25M
Enterprise Value
72.84K
1-Year Change
1.55%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.38M to $3.25M, a decrease of -87.21%. That is a compound annual growth rate of -59.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 3.16M | -57.32% |
| Dec 31, 2024 | 7.40M | 325.43% |
| Dec 29, 2023 | 1.74M | -93.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |